Worried about prostate cancer? You're not alone. Prostate cancer is common in men over 50, and many cases are slow-growing. That makes early detection and the right plan for you the most useful things to focus on.
Most screening starts with a PSA blood test and a digital rectal exam (DRE). PSA measures a prostate protein in the blood; doctors often flag values above about 4 ng/mL, but age, prostate size, and infections can change that. A high PSA or an abnormal DRE usually leads to imaging (MRI) and a biopsy. Biopsy samples give a Gleason score or Grade Group that shows how aggressive the cancer is.
Screening has pros and cons. It can catch cancers early, but it can also find slow tumors that may never cause trouble. Men aged 55–69 usually discuss PSA testing with their doctor and make a shared decision based on personal risk. If you have a father or brother with prostate cancer or are of African ancestry, bring that up—your risk may be higher.
Treatment depends on cancer grade, stage, overall health, and your priorities. For low-risk cancers, many doctors offer active surveillance: regular PSA checks, imaging, and periodic biopsies. This avoids side effects while watching the tumor closely.
For cancers that need treatment, common options include:
- Surgery (radical prostatectomy): removes the prostate. Good for localized disease, but can cause urinary incontinence and erectile dysfunction. Ask about nerve-sparing techniques and pelvic floor rehab.
- Radiation therapy: external beam or brachytherapy (seeds). Side effects may include urinary irritation, bowel changes, and sexual side effects.
- Hormone therapy (androgen deprivation): lowers testosterone to slow cancer growth. Often used with radiation or for advanced disease. It can cause hot flashes, low energy, and bone loss.
- Chemotherapy and newer systemic drugs: used for advanced or resistant cancer. Some treatments target specific mutations—your oncologist can test for those.
Side effects matter. Talk openly with your team about risks, recovery time, and quality-of-life trade-offs. Physical therapy for pelvic floor muscles, erectile rehabilitation, and support groups can help recovery.
What you can do right now: keep a record of any urinary changes, blood in urine or semen, new bone pain, or unexplained weight loss. If you have symptoms or a family history, schedule a visit. If you already have a diagnosis, consider a second opinion for major decisions.
Want related practical reads? We cover BPH medications like Flomax and the role of finasteride—useful if you’re sorting prostate issues that aren’t cancer. For any serious concern, rely on a urologist or oncologist for personalized advice.
Prostate cancer decisions are personal. Ask clear questions, weigh benefits and harms, and pick the path that fits your life and health goals.
As a blogger, I recently came across an interesting topic about Flutamide in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). Flutamide is an antiandrogen medication that has shown promise in treating this specific type of prostate cancer, which is particularly challenging due to its resistance to hormone therapy. Studies have indicated that Flutamide can help slow down the progression of nmCRPC by blocking the effects of testosterone, thus inhibiting cancer cell growth. However, further research is needed to confirm its long-term efficacy and safety for patients. Overall, Flutamide seems to be a promising treatment option for those suffering from nmCRPC, and I'm excited to see what future studies reveal about its potential benefits.
© 2025. All rights reserved.